ELIZABETH SIMPKINS: Open Payments
NPI 1881636751 · MEYERSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 72 payments from 30 companies in 2025. Trend: 2023 $122 · 2024 $1,399 · 2025 $1,654
Food & beverage: $1,454Education: $200
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $253 |
| Astellas Pharma US Inc | 3 | $168 |
| Incyte Corporation | 8 | $160 |
| AstraZeneca Pharmaceuticals LP | 5 | $114 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| GlaxoSmithKline, LLC. | 4 | $98 |
| Celgene Corporation | 5 | $90 |
| Genentech USA, Inc. | 4 | $79 |
| PFIZER INC. | 3 | $69 |
| Daiichi Sankyo Inc. | 3 | $59 |
Products named: ERLEADA, JAKAFI, KEYTRUDA, Enhertu, REBLOZYL, Vyloy, RYBREVANT, ZEJULA.
Industry payments across PA — which companies pay providers there.
